Aerie Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 18 Posts
1 2
5 Best-Rated Stocks Trending Into 2018
Article By: TipRanks Sunday, December 24, 2017 1:34 PM EST
Which 5 stocks have all the top analysts buzzing right now? We crunched the data and pinpointed five very compelling ‘strong buy’ stocks that are trending into 2018.
In this article: AMZN, MU, ONCE, AERI, SGH
Read
Track These ‘Strong Buy’ Stocks Set To Leap Higher In Q4
Article By: TipRanks Friday, September 29, 2017 5:34 AM EST
As we are entering the final quarter for 2017, I wanted to take a look ahead and see which top stocks are set to spike this quarter and beyond. Here are five stocks for your portfolio.
In this article: CBS, MU, AERI, HRTX, HUBS
Read
3 Top Stocks In The Last 72 Hours (And 1 Stock Warning)
Article By: TipRanks Sunday, May 28, 2017 4:17 PM EST
We filtered the options to best-rated stocks in the last 72 hours from any sector and with any market cap size. We crunched the data and the results came out as these three ‘strong buy’ stocks: NeoGenomics, Broadcom and Aerie Pharma.
In this article: ANF, AVGO, AERI, NEO
Read
Weekend Update And Top Current Holdings - 10/23/2016
Article By: Joshua Hayes Sunday, October 23, 2016 3:53 AM EST
Starting on Monday seasonality is back in the favor of the bulls and now all the market has to do is confirm the seasonality and we should be off and running.
In this article: CLR, GGB, HNR, HBP, AOSL, CYBE, AERI, MIME, GRAM
Read
Weekend Update And Top Current Holdings - 10/9/2016
Article By: Joshua Hayes Sunday, October 9, 2016 7:13 AM EST
Raising cash is never an issue in a truly weak market as new long signals fail, old long signals hit profit target levels, and nothing new triggers on the long side.
In this article: CLR, HNR, AOSL, SIMO, DUST, EBIO, JDST, AERI, MIME, GRAM
Read
6 Best Performing Drug Stocks Of September 2016
Article By: Arpita Dutt Monday, October 3, 2016 12:05 PM EST
Quite a few pharma and biotech stocks had an impressive run in the month of September thanks to acquisition announcements, positive data readouts, and FDA approvals. Here is a look at 6 of the best-performing drug stocks of September.
In this article: ARRY, CLVS, SRPT, VTAE, AERI, TBRA
Read
Weekend Update And Top Current Holdings
Article By: Joshua Hayes Sunday, September 25, 2016 8:23 AM EST
Stocks closed out a very bullish week with semi-moderate losses on Friday. The DJIA and RUT led the way to the downside but volume was lower across the board.
In this article: REN, QQQ, DIA, CRBP, CLR, EBIO, AERI, MIME, GRAM, IWM
Read
Weekend Update And Top Current Holdings- 9/18/2016
Article By: Joshua Hayes Sunday, September 18, 2016 3:43 PM EST
The move in the overall market the past week is yet another perfect example of why you obey your stops and not your emotions.
In this article: FN, CLR, HBP, AOSL, EBIO, QLYS, AERI, MIME, GRAM, SSTK
Read
Biopharma Stocks Show Resilience In Yo-Yo Week
Article By: Rod Raynovich Friday, September 16, 2016 1:44 AM EST
Traders “whipsawed” biotech stocks but still the IBB managed to hold onto short-term gains of 10 points over the intermediate support of $280.
In this article: AGN, BMY, ACRX, IBB, AMGN, GILD, XBI, VTAE, BLUE, AERI
Read
Aerie Surges Over 60% After Eyecare Drug Meets Primary Endpoint
Article By: The Fly Wednesday, September 14, 2016 10:41 PM EST
Shares of Aerie Pharmaceuticals surged after the company said a late-stage study of Roclatan, its eye drop combination designed to lower intraocular pressure in patients with glaucoma or ocular hypertension, met its primary endpoint.
In this article: AERI
Read
Premarket Biotech Digest 2016-03-29: ACAD Nuplazid Review, APRI Tumbles, PBYI Delays NDA Filing
Article By: KKD Healthcare Analytics Tuesday, March 29, 2016 8:31 AM EST
Daily premarket biotech digest
In this article: ACAD, ALDR, EGRX, AXSM, BPMX, PBYI, AERI, APRI, AGLE
Read
E A Market Opportunity Not Yet Priced Into Aerie Pharmaceuticals, Inc.
Article By: Samuel Rae Monday, September 21, 2015 1:33 PM EST
A detailed look at why a redesigned trial could be the key to a discounted exposure to some upsides in Aerie Pharma.
In this article: AERI
Read
E Aerie Pharmaceuticals Announces Positive Results For Phase 3 Rhopressa Trial
Article By: Terry Chrisomalis Wednesday, September 16, 2015 7:09 PM EST
Shares of Aerie Pharmaceuticals are up 75% in after hours trade after the company announced positive phase 3 results for its Rhopressa eyedrops trial.
In this article: AERI
Read
Cantor Fitzgerald's Caroline Corner: Cutting-Edge Devices And Diagnostics Deliver Drugs And Profits
Article By: The Life Sciences Report Tuesday, August 4, 2015 11:47 AM EST
Caroline Corner of Cantor Fitzgerald follows companies with technologies that can both address dire diseases and reap windfalls for investors. Corner brings important names to investors' attention.
In this article: AGN, AEMD, CERS, D-STEM (DEFUNCT), NVIV, AERI, GKOS Also: RHHBY, ALIM, REGN, ONVO, XENT, MRK
Read
Analyst Reviews Aerie Pharmaceuticals, Inc. In Light Of FDA Agreement
Article By: TipRanks Tuesday, June 16, 2015 11:48 AM EST
Aerie Pharmaceuticals, Inc. has created a lot of buzz this morning as shares jumped 56% in pre-market trading following news that the FDA has allowed the company to modify the primary endpoint of its second Phase 3 trial of Rhopressa. timolol
In this article: AERI
Read
Tuesday Morning Pre-Market Insights: AERI, NOK, AAVL, TNXP
Article By: TipRanks Tuesday, June 16, 2015 8:36 AM EST
Tuesday Morning Pre-Market Insights: AERI, NOK, AAVL, TNXP
In this article: AAVL, AERI, NOK, TNXP
Read
1 to 16 of 18 Posts
1 2